Taiyuan, China

Xin Liu

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Shanxi Jinbo Bio-Pharmaceutical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xin Liu. Retrieved from https://idiyas.com/inventor/xin-liu-skomc2a2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Xin Liu

Introduction

Xin Liu is a notable inventor based in Taiyuan, China. He has made significant contributions to the field of bio-pharmaceuticals. His work focuses on innovative solutions that enhance health and wellness.

Latest Patents

Xin Liu holds a patent for "Collagen and Use Thereof." This invention showcases his commitment to advancing medical and health-related technologies. The patent reflects his expertise in bio-pharmaceutical applications.

Career Highlights

Xin Liu is associated with Shanxi Jinbo Bio-Pharmaceutical Co., Ltd. His role in the company has allowed him to explore and develop groundbreaking innovations. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Xin Liu collaborates with talented individuals such as Yongjian Zhang and Xia Yang. Their combined efforts contribute to the advancement of bio-pharmaceutical research and development.

Conclusion

Xin Liu's contributions to the field of bio-pharmaceuticals through his patent and collaborations highlight his innovative spirit. His work continues to inspire advancements in health-related technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…